Accelerated coronary artery calcification in mildly reduced renal function of high-risk hypertensives: a 3-year

Michael Bursztyn1, Michael Motro, Ehud Grossman

  • 1Department of Medicine, Hadassah University Hospital, Mount Scopus, Jerusalem, Israel. bursz@cc.huij.ac.il

Journal of Hypertension
|September 26, 2003
PubMed

Insights

Mild renal dysfunction significantly accelerates coronary artery calcifications. This progression is two-fold greater in patients with reduced kidney function compared to those with normal function.

Area of Science:

  • Cardiology
  • Nephrology
  • Medical Imaging

Background:

  • Coronary artery calcifications (CAC) are a marker of atherosclerosis.
  • Renal dysfunction is increasingly recognized as a cardiovascular risk factor.
  • The impact of mild renal dysfunction on CAC progression requires further investigation.

Purpose of the Study:

  • To investigate the association between mild renal dysfunction and the progression of coronary artery calcifications.
  • To quantify the effect of reduced creatinine clearance on atherosclerosis burden in high-risk hypertensive patients.

Main Methods:

  • Prospective study of 313 high-risk hypertensive patients over 3 years.
  • Coronary artery calcifications assessed using dual-section spiral computed tomography (total coronary artery calcium score).
  • Patients categorized into renal dysfunction (creatinine clearance ≤ 60 ml/min) and normal renal function groups.

Main Results:

  • Coronary artery calcium score progression was two-fold higher in the renal dysfunction group compared to the normal group (P = 0.006).
  • Mild renal dysfunction was an independent predictor of accelerated CAC progression (OR 2.1).
  • Thiazide-based therapy was associated with faster CAC progression than nifedipine.

Conclusions:

  • Mild renal dysfunction accelerates coronary artery calcifications.
  • This effect is independent of traditional cardiovascular risk factors.
  • Renal function status should be considered in cardiovascular risk assessment.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...